James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $561.48 ($5.7M) on 2026-05-28, disclosed to the SEC on 2026-05-29.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $561.48 | 320 | $180K | 3.2% |
| 2 | $562.77 | 1,961 | $1.1M | 19.5% |
| 3 | $563.87 | 1,675 | $944K | 16.7% |
| 4 | $564.82 | 1,208 | $682K | 12.1% |
| 5 | $566.00 | 893 | $505K | 8.9% |
| 6 | $566.87 | 934 |
| $529K |
| 9.4% |
| 7 | $567.91 | 1,605 | $912K | 16.1% |
| 8 | $568.90 | 844 | $480K | 8.5% |
| 9 | $570.50 | 332 | $189K | 3.3% |
| 10 | $571.48 | 228 | $130K | 2.3% |
| Total | $565.63 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |